Tag: meeting

Oslo, 7 August 2025

HY25 results webcast to take place on 
Thursday, 28 August 2025 at 3pm CEST

 Exhale Wellness introduces new THC gummies in 2025, including Delta-9, Sleep, and CBD hybrid options for flavor, balance, and targeted cannabinoid support.

Suominen Corporation’s Half-Year Financial Report on August 7, 2025, at 9:30 a.m. (EEST)

Suominen Corporation’s Half-Year Financial Report for January 1 – June 30, 2025:

VEON 2Q25 Earnings Release: Direct Digital Revenues Up 57% YoY. Solid Execution, Strong Results

Wilmington, DE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Aifeex Nexus Acquisition Corporation (Nasdaq: AIFE) (“AIFE”) announced that, following receipt of shareholder approval at an Extraordinary General Meeting of Shareholders on August 5, 2025, it has filed an amendment to its Second Amended and Restated Memorandum and Articles of Association (the “Memorandum and Articles”) with the Cayman Islands Registrar of Companies to reflect a corporate name change from “Aifeex Nexus Acquisition Corporation” to “Pantages Capital Acquisition Corporation.” The Company’s ticker symbols for its units, ordinary shares and rights will change from “AIFEU”, “AIFE”, “AIFER”, in each case to “PGACU”, “PGAC”, and “PGACR” commencing on or about August 8, 2025.

CALGARY, Alberta, Aug. 06, 2025 (GLOBE NEWSWIRE) -- NuVista Energy Ltd. ("NuVista" or the "Company") (TSX: NVA) is pleased to announce financial and operating results for the three and six months ended June 30, 2025, and to provide an update on our operational performance. We have continued to advance our business with the goal of creating top-tier returns for our shareholders. Our predictable and repeatable development plan continues to produce improved capital efficiencies, allowing us to reduce our capital expenditures guidance both this year and next and deliver average annual per share production growth of at least 15%. In the third quarter, we will be ramping up production toward 100,000 Boe/d and our 5-year outlook of growing production to 125,000 Boe/d remains fully in-tact and will be achieved with less capital than originally expected. With respect to returns to shareholders, we have directed over $100 million toward share repurchases in the first half of the year and continue to believe a balanced approach to absolute growth and share repurchases will drive superior total returns.